Suchergebnisse - "Sayon, Sophie"

PubPharm (49)

1

Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies

enthalten in: The Journal of infectious diseases | 2023

von Leducq, V. | Zafilaza, K. | Fauchois, A. | +111

2

Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients

enthalten in: Med (New York, N.Y.) | 2023

von Bruel, T. | Vrignaud, L. | Porrot, F. | +122

3

High rate of early HEV seroconversion after liver transplantation among cirrhotic patients : Should we test for it?

enthalten in: The Journal of infection | 2023

von Mazzola, A. | Todesco, E. | Ali, S. | +10

4

Long-term evolution of humoral immune response after SARS-CoV-2 infection

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Teyssou, E. | Zafilaza, K. | Sayon, S. | +9

5

Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients

enthalten in: The Journal of infectious diseases | 2022

von Palich, R. | Teyssou, E. | Sayon, S. | +12

6

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies

enthalten in: Viruses | 2022

von Jary, A. | Marot, S. | Faycal, A. | +13

7

Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi's Sarcoma Treatment

enthalten in: Cancers | 2022

von Gothland, A. | Leducq, V. | Grange, P. | +10

8

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

enthalten in: bioRxiv.org | 2021

von Teyssou, E. | Soulie, C. | Visseaux, B. | +17

9

Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Abdi, B. | Lambert-Niclot, S. | Wirden, M. | +12

10

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

enthalten in: The Journal of infection | 2021

von Teyssou, E. | Soulie, C. | Visseaux, B. | +17

1
2
3
4
5
Nächster »
[5]